Article
Disposition and mass balance of [14C]vernakalant after single intravenous and oral doses in healthy volunteers.
Drug metabolism letters - 1 Apr 2011
Mao Z L, Alak A, Wheeler J J, Keirns J
Abstract excerpt
Vernakalant hydrochloride is a novel antiarrhythmic drug for the rapid conversion of atrial fibrillation to sinus rhythm and prevention of relapse. In this open-label, parallel design study, 8 healthy men received single 240-mg doses of [(14)C]vernakalant hydrochloride, given as a 10-minute intravenous (IV) infusion on day 1, and as an oral gel capsule on day 22. Plasma, urine, and fecal samples were collected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
